Marinus Pharmaceuticals Inc (MRNS)
1.41
+0.07
(+5.22%)
USD |
NASDAQ |
May 15, 13:30
Marinus Pharmaceuticals Profit Margin (Quarterly): -503.6% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -503.6% |
December 31, 2023 | -580.9% |
September 30, 2023 | -449.3% |
June 30, 2023 | -525.1% |
March 31, 2023 | -334.6% |
December 31, 2022 | -479.1% |
September 30, 2022 | |
June 30, 2022 | -2.20K% |
Date | Value |
---|---|
March 31, 2022 | -136.5% |
December 31, 2021 | -1.86K% |
September 30, 2021 | -192.9% |
June 30, 2021 | -1.25K% |
March 31, 2021 | -1.50K% |
December 31, 2020 | -1.13K% |
September 30, 2020 | -9.16K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.16K%
Minimum
Sep 2020
-136.5%
Maximum
Mar 2022
-1.45K%
Average
-553.0%
Median
Profit Margin (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | -- |
Soligenix Inc | -- |
Actinium Pharmaceuticals Inc | -- |
Macrogenics Inc | -573.3% |
ADMA Biologics Inc | 21.75% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -368.3% |
Return on Assets | -77.55% |
Return on Invested Capital | -129.5% |
Gross Profit Margin (Quarterly) | 90.16% |
Operating Margin (Quarterly) | -466.5% |
Return on Net Operating Assets | -1.08K% |